½ÃÀ庸°í¼­
»óǰÄÚµå
1567798

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ¿¹Ãø(-2030³â) : Áö¿ª ºÐ¼® - ½Ç½Ã À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°

North America Medical Ultrasound Flow Meter Market Forecast to 2030 - Regional Analysis - by Implementation Type, Technology, Application, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 153 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº 2022³â 7,440¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2030³â¿¡´Â 1¾ï 5,277¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³âºÎÅÍ 2030³â±îÁö 9.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÉÇ÷°üÁúȯ°ú È£Èí±âÁúȯÀÇ Áõ°¡·Î ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ¼ºÀå ÃËÁø

½ÉÇ÷°üÁúȯ(CVD)À¸·Î ÀÎÇÑ »ç¸ÁÀÚ´Â Àü ¼¼°èÀûÀ¸·Î ¸Å³â ¼ö¹é¸¸ ¸í¿¡ ´ÞÇϸç, 2022 Heart Disease &Stroke Statistical Update Fact Sheet, Global Burden of Disease¿¡ µû¸£¸é 2020³â¿¡´Â 1¾ï 1,910¸¸ ¸íÀÇ È¯ÀÚ°¡ CVD·Î ÀÎÇØ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ CVD·Î ÀÎÇØ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, 2020³â ³úÁ¹Áß°ú ÇãÇ÷¼º ³úÁ¹ÁßÀÇ Àü ¼¼°è À¯º´·üÀº °¢°¢ 8,910¸¸ ¸í°ú 6,820¸¸ ¸íÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¹Ì±¹ ±¹¸³¸¸¼ºÁúȯ¿¹¹æ¼¾ÅÍ(National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention)¿¡ µû¸£¸é 2022³â ³â ¹Ì±¹¿¡¼­ ½ÉÀ庴¿¡ °É¸° »ç¶÷Àº 697,000¸íÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ¿¡ µû¸£¸é, 2035³â±îÁö ¹Ì±¹¿¡¼­´Â 1¾ï 3,000¸¸ ¸í ÀÌ»ó(Àüü Àα¸ÀÇ 45.1%)ÀÌ ¾î¶² ÇüÅÂ·Îµç ½ÉÇ÷°üÁúȯÀ» ¾Î°Ô µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ±¹¸³ÀÇÇеµ¼­°ü¿¡ µû¸£¸é 2022³â¿¡´Â ¾à 40¸¸ °ÇÀÇ °ü»óµ¿¸Æ ¿ìȸ¼ú(CABG) ¼ö¼úÀÌ ½ÃÇàµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)Àº ÆóÀÇ °ø±â È帧À» ¹æÇØÇÏ¿© È£ÈíºÎÀüÀ» ÀÏÀ¸Å°´Âµ¥, COPD´Â Àü ¼¼°èÀûÀ¸·Î ¼ö¹é¸¸ ¸íÀÇ »ç¸ÁÀÚ¸¦ ¹ß»ý½ÃŰ´Â »ý¸íÀ» À§ÇùÇÏ´Â Áúº´ Áß ÇϳªÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é COPD´Â 2022³â »ç¸Á ¿øÀÎ 3À§¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2020³â COPD·Î ÀÎÇÑ »ç¸ÁÀÇ ¾à 90%°¡ ÁßÀú¼Òµæ ±¹°¡¿¡¼­ ¹ß»ýÇÕ´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é 2020³â COPD´Â ¹Ì±¹ ³» »ç¸Á ¿øÀÎ 6À§¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌó·³ CVD ¹× È£Èí±âÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ÃÊÀ½ÆÄ À¯·®°è°¡ ³»ÀåµÈ ü¿Ü º¸Á¶ ÀåÄ¡ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀÇ·á¿ë Æ©ºê¸¦ ÅëÇØ ȯÀÚÀÇ ¸ö¿¡ ü¾×À» °ø±ÞÇÏ´Â ÀϽÃÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â »ý¸í À¯Áö ½Ã½ºÅÛÀΠü¿Ü¸· »ê¼Ò ¿ä¹ý(ECMO)Àº ¼ö¼ú Áß »ê¼Ò¸¦ Æ÷ÇÔÇÑ Ç÷¾×ÀÇ Á¤È®ÇÑ È帧À» º¸ÀåÇϱâ À§ÇØ ½ÉÀåÀ̳ª Æó¸¦ ´ë½ÅÇÏ¿© ÀÛµ¿ÇÏ´Â ÃÊÀ½ÆÄ À¯·®°è°¡ ³»ÀåµÇ¾î ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå °³¿ä

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. ½ÉÇ÷°ü ¹× È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ½ÃÀå ±â¾÷ÀÇ Àü·«Àû °³¹ß È®´ë°¡ ÀÌ Áö¿ªÀÇ ½ÃÀå ¹ßÀü¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÌ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀÇ ÁÖ¿ä Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ¼¼ºÐÈ­

ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº ±¸Çö, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× ±¹°¡·Î ºÐ·ùµË´Ï´Ù.

½ÇÇà À¯Çüº°·Î ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº Ŭ·¥ÇÁ¿Â, ÀζóÀÎ, ±âŸ·Î ±¸ºÐµË´Ï´Ù. Ŭ·¥ÇÁ¿Â ºÎ¹®ÀÌ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±â¼úº°·Î ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº µµÇ÷¯, Æ®·£ÁþŸÀÓ, ÇÏÀ̺긮µå·Î ºÐ·ùµË´Ï´Ù. µµÇ÷¯ ºÎ¹®ÀÌ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº ½ÉÀå ¹× Æó ÀåÄ¡, ü¿Ü¸· »ê¼ÒÈ­, °ü·ù, Àå±â ÀÌ¼Û ½Ã½ºÅÛ, ±âŸ·Î ºÐ·ùµÇ¸ç, 2022³â ±âŸ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ¿¬±¸¼Ò ¹× ±âŸ·Î ±¸ºÐµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµÇ¸ç, 2022³â ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå Á¡À¯À²Àº ¹Ì±¹ÀÌ µ¶½ÄÇß½À´Ï´Ù.

Arjo AB, PSG Dover, Moor Instruments Ltd, Transonic Systems Inc, Compumedics Ltd, Cook Medical Holdings LLC, GF Health Products Inc, Sonotec GmbH, Strain Measurement Devices Inc, Siemens AG, Perimed AB, Sensirion Holding AG µîÀÌ ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°üÁúȯ°ú È£Èí±âÁúȯ Áõ°¡
    • ÀÌ½Ä ¼ö¼ú ¿ä±¸ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÃÊÀ½ÆÄ À¯·®°èÀÇ °íºñ¿ë°ú ÀúÁ¤È®µµ
  • ½ÃÀå ±âȸ
    • °¢»çÀÇ µ¿Çâ
  • ÇâÈÄ µ¿Çâ
    • ±â¼úÀÇ Áøº¸¿Í ¿¬±¸°³¹ß Ȱµ¿ Áõ°¡
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®

  • ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ¸ÅÃâ, 2020-2030³â

Á¦6Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ºÐ¼® : ½Ç½Ã À¯Çüº°

  • Ŭ·¥ÇÁ¿Â
  • ÀζóÀÎ
  • ±âŸ

Á¦7Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ºÐ¼® : ±â¼úº°

  • µµÇ÷¯
  • Æ®·£ÁþŸÀÓ
  • ÇÏÀ̺긮µå

Á¦8Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ½ÉÀ塤Æó Àåºñ
  • ü¿Ü¸·»ê¼ÒÈ­ Àåºñ
  • °ü·ù
  • Àå±â ÀÌ¼Û ½Ã½ºÅÛ
  • ±âŸ

Á¦9Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø ¹× Áø·á¼Ò
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦10Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀå : ±¹°¡º°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦11Àå ¾÷°è »óȲ

  • ÀÇ·á¿ë ÃÊÀ½ÆÄ À¯·®°è ½ÃÀåÀÇ ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Arjo AB
  • PSG Dover
  • Moor Instruments Ltd
  • Transonic Systems Inc
  • Compumedics Ltd
  • Cook Medical Holdings LLC
  • GF Health Products Inc
  • Sonotec GmbH
  • Strain Measurement Devices Inc
  • Siemens AG
  • Perimed AB
  • Sensirion Holding AG

Á¦13Àå ºÎ·Ï

ksm 24.10.24

The North America medical ultrasound flow meter market was valued at US$ 74.40 million in 2022 and is projected to reach US$ 152.77 million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030.

Rising Number of Cardiovascular and Respiratory Diseases Fuels North America Medical Ultrasound Flow Market

Millions of deaths are recorded due to cardiovascular diseases (CVDs) annually across the world. According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, 119.1 million patients succumbed to death globally due to CVD in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people were reported to have had heart disease in the US in 2022. According to the American Heart Association, over 130 million people in the US (45.1% of the total population) are likely to be affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, about 400,000 coronary artery bypass grafting (CABG) surgeries were performed in 2022.

Chronic obstructive pulmonary disease (COPD) obstructs the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to the World Health Organization (WHO), COPD was the third leading cause of death in 2022. In 2020, about 90% of COPD deaths occurred in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Thus, the increasing number of CVDs and respiratory diseases has promoted the growing use of external support devices incorporated with ultrasound flow meters. For instance, extracorporeal membrane oxygenation (ECMO)-a life support system that provides a temporary solution for pumping fluids in the patient's body through medical tubing-is incorporated with ultrasound flow meters to work in place of heart or lungs in order to ensure the accurate flow of oxygenated blood during surgical procedures.

North America Medical Ultrasound Flow Meter Market Overview

The North America medical ultrasound flow meter market is segmented into the US, Canada, and Mexico. The rising prevalence of cardiovascular diseases and respiratory diseases and growing strategic developments by market players contribute to the market development in the region. The US holds the leading medical ultrasound flow meter market share.

North America Medical Ultrasound Flow Meter Market Revenue and Forecast to 2030 (US$ Million)

North America Medical Ultrasound Flow Meter Market Segmentation

The North America medical ultrasound flow meter market is categorized into implementation, technology, application, end user, and country.

Based on implementation, the North America medical ultrasound flow meter market is segmented into clamp-on, inline, and others. The clamp-on segment held the largest market share in 2022.

In terms of technology, the North America medical ultrasound flow meter market is categorized into doppler, transit-time, and hybrid. The doppler segment held the largest market share in 2022.

By application, the North America medical ultrasound flow meter market is segmented into heart and lung machines, extracorporeal membrane oxygenation, perfusion, organs transportation system, and others. The others segment held the largest market share in 2022.

By end user, the North America medical ultrasound flow meter market is bifurcated into hospitals and clinics, ambulatory surgical centers, research laboratories, and others. The hospitals and clinics segment held the largest market share in 2022.

By country, the North America medical ultrasound flow meter market is segmented into the US, Canada, and Mexico. The US dominated the North America medical ultrasound flow meter market share in 2022.

Arjo AB, PSG Dover, Moor Instruments Ltd, Transonic Systems Inc, Compumedics Ltd, Cook Medical Holdings LLC, GF Health Products Inc, Sonotec GmbH, Strain Measurement Devices Inc, Siemens AG, Perimed AB, and Sensirion Holding AG are some of the leading companies operating in the North America medical ultrasound flow meter market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Medical Ultrasound Flow Meter Market - Key Market Dynamics

  • 4.1 Medical Ultrasound Flow Meter Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Number of Cardiovascular and Respiratory Diseases
    • 4.2.2 Increasing Need for Transplant Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Low Accuracy of Ultrasonic Flow Meter
  • 4.4 Market Opportunities
    • 4.4.1 Developments by Companies
  • 4.5 Future Trends
    • 4.5.1 Technological Advancements and Increase in Research & Development Activities
  • 4.6 Impact of Drivers and Restraints:

5. Medical Ultrasound Flow Meter Market - North America Market Analysis

  • 5.1 Medical Ultrasound Flow Meter Market Revenue (US$ Thousand), 2020-2030

6. North America Medical Ultrasound Flow Meter Market Analysis - by Implementation Type

  • 6.1 Overview
  • 6.2 Clamp-On
    • 6.2.1 Overview
    • 6.2.2 Clamp-On: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.3 Inline
    • 6.3.1 Overview
    • 6.3.2 Inline: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)

7. North America Medical Ultrasound Flow Meter Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Doppler
    • 7.2.1 Overview
    • 7.2.2 Doppler: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.3 Transit Time
    • 7.3.1 Overview
    • 7.3.2 Transit Time: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Hybrid
    • 7.4.1 Overview
    • 7.4.2 Hybrid: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)

8. North America Medical Ultrasound Flow Meter Market Analysis - by Application

  • 8.1 Overview
  • 8.2 Heart and Lung Machine
    • 8.2.1 Overview
    • 8.2.2 Heart and Lung Machine: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.3 Extracorporeal Membrane Oxygenation
    • 8.3.1 Overview
    • 8.3.2 Extracorporeal Membrane Oxygenation: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.4 Perfusion
    • 8.4.1 Overview
    • 8.4.2 Perfusion: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.5 Organ Transportation Systems
    • 8.5.1 Overview
    • 8.5.2 Organ Transportation Systems: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)

9. North America Medical Ultrasound Flow Meter Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
    • 9.2.1 Overview
    • 9.2.2 Hospitals and Clinics: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Overview
    • 9.3.2 Ambulatory Surgical Centers: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.4 Research Laboratories
    • 9.4.1 Overview
    • 9.4.2 Research Laboratories: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)

10. North America Medical Ultrasound Flow Meter Market - Country Analysis

  • 10.1 North America: Medical Ultrasound Flow Meter Market Overview
    • 10.1.1 North America: Medical Ultrasound Flow Meter Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 United States: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 10.1.1.1.3 United States: Medical Ultrasound Flow Meter Market Breakdown, by Implementation Type
        • 10.1.1.1.4 United States: Medical Ultrasound Flow Meter Market Breakdown, by Technology
        • 10.1.1.1.5 United States: Medical Ultrasound Flow Meter Market Breakdown, by Application
        • 10.1.1.1.6 United States: Medical Ultrasound Flow Meter Market Breakdown, by End User
      • 10.1.1.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 10.1.1.2.3 Canada: Medical Ultrasound Flow Meter Market Breakdown, by Implementation Type
        • 10.1.1.2.4 Canada: Medical Ultrasound Flow Meter Market Breakdown, by Technology
        • 10.1.1.2.5 Canada: Medical Ultrasound Flow Meter Market Breakdown, by Application
        • 10.1.1.2.6 Canada: Medical Ultrasound Flow Meter Market Breakdown, by End User
      • 10.1.1.3 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Medical Ultrasound Flow Meter Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 10.1.1.3.3 Mexico: Medical Ultrasound Flow Meter Market Breakdown, by Implementation Type
        • 10.1.1.3.4 Mexico: Medical Ultrasound Flow Meter Market Breakdown, by Technology
        • 10.1.1.3.5 Mexico: Medical Ultrasound Flow Meter Market Breakdown, by Application
        • 10.1.1.3.6 Mexico: Medical Ultrasound Flow Meter Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Medical Ultrasound Flow Meter Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Arjo AB
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 PSG Dover
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Moor Instruments Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Transonic Systems Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Compumedics Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Cook Medical Holdings LLC
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 GF Health Products Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Sonotec GmbH
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Strain Measurement Devices Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Siemens AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Perimed AB
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Sensirion Holding AG
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦